Skip to main content

Table 6 Serum Hormone Levels

From: Effects of eight weeks of an alleged aromatase inhibiting nutritional supplement 6-OXO (androst-4-ene-3,6,17-trione) on serum hormone profiles and clinical safety markers in resistance-trained, eugonadal males

 

300 mg

600 mg

Week

0

1

3

8

11

0

1

3

8

11

TT (ng/ml)

4.7 ± 2.1

6.2 ± 1.4

5.6 ± 2.0

5.8 ± 2.1

5.0 ± 1.0

3.9 ± 1.2

5.6 ± 1.5

5.8 ± 1.3

5.4 ± 1.9

6.29 ± 5.0

‡ FT (pg/ml)

17.2 ± 8.8

37.1 ± 33.03*

30.13 ± 17.3*

30.5 ± 16.9*

18.2 ± 10.6

22.7 ± 13.0

39.2 ± 13.2*

45.1 ± 27.0*

40.6 ± 36.1*

22.4 ± 9.8

‡ DHT (ng/mL)

0.9 ± 0.4

3.1 ± 1.8*

2.8 ± 1.4*

2.4 ± 1.3*

1.0 ± 0.3

0.9 ± 0.2

3.0 ± 1.3*

4.4 ± 3.8*

2.8 ± 1.7*

1.7 ± 1.2

Estradiol (ng/mL)

89.6 ± 86.2

112.3 ± 124.2

121.2 ± 125.6

107.1 ± 106.6

101.8 ± 103.8

69.1 ± 23.6

71.4 ± 35.9

85.5 ± 49.4

75.8 ± 47.9

78.3 ± 54.5

‡ Estriol (pg/ml)

0.04 ± 0.03

0.04 ± 0.04

0.05 ± 0.07

0.05 ± 0.06

0.06 ± 0.05

0.03 ± 0.04

0.04 ± 0.05

0.04 ± 0.03

0.05 ± 0.03

0.04 ± 0.02

‡ T/E

0.2 ± 0.1

0.3 ± 0.3*

0.3 ± 0.1*

0.3 ± 0.2*

0.2 ± 0.1

0.3 ± 0.2

0.6 ± 0.4*

0.5 ± 0.1*

0.5 ± 0.5*

0.3 ± 0.2

Estrone (pg/ml)

334.1 ± 89.5

428.8 ± 122.*

400.9 ± 135.4*

397.2 ± 166.0*

323.5 ± 89.3

268.8 ± 43.7

425.3 ± 137.0*

431.7 ± 141.6*

365.6 ± 92.0*

308.8 ± 101.6

† SHBG (nmol/L)

128.9 ± 36.6

135.7 ± 33.5

127.4 ± 37.3

137.0 ± 42.5

132.5 ± 43.5

130.6 ± 26.6*

119.5 ± 32.6*

106.9 ± 17.6*

101.4 ± 29.5*

112.9 ± 35.8*

†LH (mIU/ml)

6.6 ± 4.2

8.9 ± 5.6

6.0 ± 3.2

6.3 ± 3.0

5.4 ± 2.4

3.2 ± 1.8*

4.5 ± 2.1*

4.3 ± 1.9*

4.1 ± 2.6*

3.9 ± 2.6*

† FSH (mIU/ml)

0.03 ± 0.04

0.04 ± 0.06

0.03 ± 0.03

0.06 ± 0.06

0.03 ± 0.05

0.1 ± 0.2*

0.09 ± 0.3*

0.03 ± 0.07*

0.08 ± 0.2*

0.2 ± 0.4*

Cortisol (μg/dl)

23.0 ± 7.1

24.3 ± 7.3

23.6 ± 4.1

19.5 ± 8.9

22.4 ± 5.0

24.5 ± 6.5

25.4 ± 4.1

25.5 ± 3.6

26.3 ± 8.1

24.9 ± 4.9

GH (pg/ml)

46.9 ± 9.7

59.7 ± 150.7

62.4 ± 44.1

82.2 ± 64.2

107.6 ± 284.4

56.8 ± 114.1

49.7 ± 72.1

119.4 ± 306.2

63.4 ± 43.7

165.8 ± 254.1

  1. † Significant main effect for Group (p < 0.05). ‡ Significant main effect for Test (p < 0.05). * Significantly different from baseline (Week 0) (p < 0.05).